# Doppler or Amniocentesis to Predict Fetal Anemia

> **NCT00295516** · PHASE3 · COMPLETED · sponsor: **University of Toronto** · enrollment: 157 (—)

## Conditions studied

- Rh Isoimmunization

## Interventions

- **PROCEDURE:** Fetal Middle Cerebral Artery Doppler measurement

## Key facts

- **NCT ID:** NCT00295516
- **Lead sponsor:** University of Toronto
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2000-10
- **Primary completion:** —
- **Final completion:** 2004-08
- **Target enrollment:** 157 (—)
- **Last updated:** 2006-05-24

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00295516

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00295516, "Doppler or Amniocentesis to Predict Fetal Anemia". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT00295516. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*